COVID-19 vaccination before or during pregnancy results in high, sustained maternal neutralizing activity to SARS-CoV-2 wild-type and Delta/Omicron variants of concern, particularly following a booster dose or infection

被引:1
|
作者
Mahyuddin, Aniza P. [1 ]
Swa, Hannah L. F. [2 ]
Weng, Ruifen [2 ]
Zhang, Jingxian [2 ]
Dhanaraj, Janice P. [2 ]
Sesurajan, Binny P. [1 ,6 ]
Rauff, Mary [1 ,3 ]
Dashraath, Pradip [1 ,3 ]
Kanneganti, Abhiram [3 ]
Lee, Rachel [3 ]
Wang, Lin-Fa [4 ,5 ]
Young, Barnaby E. [5 ,6 ,7 ,8 ,9 ]
Tambyah, Paul A. [1 ,9 ,10 ]
Lye, David C. [5 ,6 ,7 ,8 ,9 ]
Chai, Louis Y. A. [9 ,10 ]
Yee, Sidney [11 ]
Choolani, Mahesh [1 ,3 ]
Mattar, Citra N. Z. [1 ,3 ]
机构
[1] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, 1E Kent Ridge Rd,NUHS Tower Block,Level 12, Singapore 119228, Singapore
[2] Agcy Sci Technol & Res, Diagnost Dev Hub, Singapore, Singapore
[3] Natl Univ Hlth Syst, Natl Univ Hosp, Dept Obstet & Gynaecol, Singapore, Singapore
[4] Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore
[5] Natl Ctr Infect Dis, Programme Res Epidem Preparedness & Response PREPA, Singapore, Singapore
[6] Natl Ctr Infect Dis, Singapore, Singapore
[7] Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore
[8] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore
[9] Natl Univ Singapore, Yong Loo Lin Sch Med, Infect Dis Translat Res Program, Singapore, Singapore
[10] Natl Univ Singapore Hosp, Natl Univ Hlth Syst, Dept Med, Div Infect Dis, Singapore, Singapore
[11] Agcy Sci Technol & Res, Innovatione & Enterprise, Connexis North Tower, Singapore, Singapore
基金
英国医学研究理事会; 新加坡国家研究基金会;
关键词
SARS-CoV-2; Pregnancy; Vaccine effectiveness; Delta; Omicron; Surrogate virus neutralization; OMICRON;
D O I
10.1016/j.ijid.2024.107121
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To investigate multi-dose and timings of COVID-19 vaccines in preventing antenatal infection. Design: Prospective observational study investigating primary vaccinations, boosters, antenatal COVID-19 infections, neutralizing antibody (Nab) durability, and cross-reactivity to Delta and Omicron variants of concern (VOCs). Results: Ninety-eight patients completed primary vaccination prepregnancy (29.6%) and antenatally (63.3%), 24.2% of whom had antenatal COVID-19, while 7.1% were unvaccinated (28.6% had antenatal COVID-19). None had severe COVID-19. Prepregnancy vaccination resulted in vaccination-to-infection delay of 23.3 weeks, which extended to 45.2 weeks with a booster, compared to 16.9 weeks following antenatal vaccination ( P < 0.001). Infections occurred at 26.2 weeks gestation in women vaccinated prepregnancy compared to 36.2 weeks gestation in those vaccinated during pregnancy ( P < 0.007). The risk of COVID-19 infection was higher without antenatal vaccination (hazard ratio [HR] 14.6, P = 0.05) and after prepregnancy vaccination without a booster (HR 10.4, P = 0.002). Antenatal vaccinations initially led to high Nab levels, with mild waning but subsequent rebound. Significant Nab enhancement occurred with a third-trimester booster. Maternal-neonatal Nab transfer was efficient (transfer ratio > 1), and crossreactivity to VOCs was observed. Conclusion: Completing vaccination during any trimester delays COVID-19 infection and maintains effective neutralizing activity throughout pregnancy, with robust cross-reactivity to VOCs and efficient maternal-neonatal transfer. (c) 2024 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Decrease in COVID-19 adverse outcomes in adults during the Delta and Omicron SARS-CoV-2 waves, after vaccination in Mexico
    Dominguez-Ramirez, Lenin
    Solis-Tejeda, Itzel
    Ayon-Aguilar, Jorge
    Mayoral-Ortiz, Antonio
    Sosa-Jurado, Francisca
    Pelayo, Rosana
    Santos-Lopez, Gerardo
    Cortes-Hernandez, Paulina
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [32] Reactogenicity, pregnancy outcomes, and SARS-CoV-2 infection following COVID-19 vaccination during pregnancy in Canada: A national prospective cohort study
    Mcclymont, E.
    Atkinson, A.
    Albert, A.
    Av-Gay, G.
    Andrade, J.
    Barrett, J.
    Bogler, T.
    Boucoiran, I.
    Castillo, E.
    D'Souza, R.
    El-Chaar, D.
    Fadel, S.
    Fell, D. B.
    Korchinski, I.
    Kuret, V.
    Ogilvie, G.
    Poliquin, V.
    Sadarangani, M.
    Scott, H.
    Snelgrove, J. W.
    Tunde-Byass, M.
    Money, D.
    VACCINE, 2023, 41 (48) : 7183 - 7191
  • [33] Protection From COVID-19 mRNA Vaccination and Prior SARS-CoV-2 Infection Against COVID-19-Associated Encounters in Adults During Delta and Omicron Predominance
    Bozio, Catherine H.
    Butterfield, Kristen A.
    Hagen, Melissa Briggs
    Grannis, Shaun
    Drawz, Paul
    Hartmann, Emily
    Ong, Toan C.
    Fireman, Bruce
    Natarajan, Karthik
    Dascomb, Kristin
    Gaglani, Manjusha
    DeSilva, Malini B.
    Yang, Duck-Hye
    Midgley, Claire M.
    Dixon, Brian E.
    Naleway, Allison L.
    Grisel, Nancy
    Liao, I. Chia
    Reese, Sarah E.
    Fadel, William F.
    Irving, Stephanie A.
    Lewis, Ned
    Arndorfer, Julie
    Murthy, Kempapura
    Riddles, John
    Valvi, Nimish R.
    Mamawala, Mufaddal
    Embi, Peter J.
    Thompson, Mark G.
    Stenehjem, Edward
    JOURNAL OF INFECTIOUS DISEASES, 2023, 227 (12): : 1348 - 1363
  • [34] Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants
    Accorsi, Emma K.
    Britton, Amadea
    Fleming-Dutra, Katherine E.
    Smith, Zachary R.
    Shang, Nong
    Derado, Gordana
    Miller, Joseph
    Schrag, Stephanie J.
    Verani, Jennifer R.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (07): : 639 - 651
  • [35] Long-term prognosis at 1.5 years after infection with wild-type strain of SARS-CoV-2 and Alpha, Delta, as well as Omicron variants
    Agergaard, Jane
    Gunst, Jesper Damsgaard
    Schiottz-Christensen, Berit
    Ostergaard, Lars
    Wejse, Christian
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 137 : 126 - 133
  • [36] Neutralization against SARS-CoV-2 Delta/Omicron variants and B cell response after inactivated vaccination among COVID-19 convalescents
    Wang, Hao
    Yuan, Yu
    Wu, Bihao
    Xiao, Mingzhong
    Wang, Zhen
    Diao, Tingyue
    Zeng, Rui
    Chen, Li
    Lei, Yanshou
    Long, Pinpin
    Guo, Yi
    Lai, Xuefeng
    Wen, Yuying
    Li, Wenhui
    Cai, Hao
    Song, Lulu
    Ni, Wei
    Zhao, Youyun
    Ouyang, Kani
    Wang, Jingzhi
    Wang, Qi
    Liu, Li
    Wang, Chaolong
    Pan, An
    Li, Xiaodong
    Gong, Rui
    Wu, Tangchun
    FRONTIERS OF MEDICINE, 2023, 17 (04) : 747 - 757
  • [37] Neutralization against SARS-CoV-2 Delta/Omicron variants and B cell response after inactivated vaccination among COVID-19 convalescents
    Hao Wang
    Yu Yuan
    Bihao Wu
    Mingzhong Xiao
    Zhen Wang
    Tingyue Diao
    Rui Zeng
    Li Chen
    Yanshou Lei
    Pinpin Long
    Yi Guo
    Xuefeng Lai
    Yuying Wen
    Wenhui Li
    Hao Cai
    Lulu Song
    Wei Ni
    Youyun Zhao
    Kani Ouyang
    Jingzhi Wang
    Qi Wang
    Li Liu
    Chaolong Wang
    An Pan
    Xiaodong Li
    Rui Gong
    Tangchun Wu
    Frontiers of Medicine, 2023, 17 : 747 - 757
  • [38] Reactogenicity, SARS- cov-2 infection, and pregnancy outcomes following COVID-19 vaccination during pregnancy in canada
    Mcclymont, E.
    Atkinson, A.
    Albert, A.
    Andrade, J.
    Barrett, J.
    Bogler, T.
    Boucoiran, I
    Castillo, E.
    D'souza, R.
    El-Chaar, D.
    Fadel, S.
    Fell, D.
    Kuret, V
    Ogilvie, G.
    Poliquin, V
    Sadarangani, M.
    Scott, H.
    Snelgrove, J.
    MTunde-Byass, M.
    Money, D.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2023, 228 (02) : S785 - S785
  • [39] Neutralization Activity against SARS-CoV-2 Variants after Booster Vaccination in Populations without COVID-19: A Meta-Analysis
    Cheng, Haoyue
    Peng, Zhicheng
    Si, Shuting
    Alifu, Xialidan
    Zhou, Haibo
    Chi, Peihan
    Zhuang, Yan
    Mo, Minjia
    Yu, Yunxian
    VACCINES, 2022, 10 (07)
  • [40] Patients With Primary Antibody Deficiency Syndromes Show Attenuated Neutralizing Activity of SARS-CoV-2 Following COVID-19 Vaccination
    Doss, Alexa
    Chen, Rita
    Monroy, Jennifer
    Wedner, H. James
    Kulczycki, Anthony
    Dy, Tiffany
    Ren, Zhen
    Kau, Andrew
    Mantia, Tarisa
    O'Shaughnessy, Caitlin
    Nickles, Brandi
    Kendall, Peggy
    Diamond, Michael
    Zimmerman, Ofer
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB64 - AB64